ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1027

Low Dose Computed Tomography Hounsfield Units: A Reliable Methodology for Assessing Changes in Vertebral Bone Density in Radiographic Axial Spondyloarthritis

Mary Lucy Marques1, Nuno Pereira da Silva2, Désirée van der Heijde3, Monique Reijnierse4, Juergen Braun5, Xenofon Baraliakos6, floris van Gaalen4 and Sofia Ramiro4, 1Leiden University Medical Center, Coimbra, Portugal, 2Radiology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 3Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 4Leiden University Medical Center, Leiden, Netherlands, 5Rheumazentrum Ruhrgebiet, Herne, Germany, 6Rheumazentrum Ruhrgebiet Herne, Herne, Germany

Meeting: ACR Convergence 2022

Keywords: Bone density, osteopenia, Outcome measures, spondyloarthritis, Spondyloarthropathies

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: In radiographic axial Spondyloarthritis (r-axSpA), low dose Computed Tomography (ldCT) Hounsfield Units (HU) were shown to cross-sectionally reliably assess bone density at each vertebra from C3 to L5.1 HU change scores have never been studied. In the present study we aimed to describe ldCT HU 2-year change scores and analyse inter-reader reliability per vertebra.

Methods: We used 49 patients with r-axSpA from the multicentre 2-year Sensitive Imaging in Ankylosing Spondylitis (SIAS) study. A standardized protocol and automatic exposure control calibration in ldCT imaging acquisition were used. HU measurements at each vertebra (from C3 to L5) were independently assessed by two trained readers at baseline and two years (independent reading sessions ≥3 months apart), according to the methodology described in Figure 1. Mean (standard deviation, SD) for the change-from-baseline HU scores were provided per vertebra by reader. Intraclass correlation coefficients (ICC; absolute agreement, two-way random effects), Bland-Altman plots and smallest detectable change (SDC) were obtained. Also, percentages of vertebrae in which readers agreed on the direction of change and on change scores >|SDC| were computed.

Results: Overall, 1,053 (98% of all possible) vertebrae were assessed at both time-points by each reader. Over two years, HU mean change values varied from -23 to 28 and 29 for reader 1 and 2, respectively – Table 1. Inter-reader reliability for the change-from-baseline scores per vertebra was excellent: ICC: 0.91 to 0.99; SDC: 6 to 10; Bland-Altman plots were homoscedastic, with negligible systematic error between readers. Readers agreed on the direction of the change-score in 88-96% and on change-scores >|SDC| in 58-94% of vertebrae, per vertebral level, from C3 to L5. Overall, similar results were obtained across all vertebrae.

Conclusion: LdCT measurement of HU is a reliable method to assess changes in bone density at each vertebra from C3 to L5. Being reliable across all vertebrae, this methodology can aid the study of bone density changes in r-axSpA, a disease affecting the whole spine.

References: 1. Marques ML, et al. Arthritis Rheumatol. 2021; 73 (suppl 10).

SIAS study was funded by the Dutch Rheumatism Association (“ReumaNederland”). MLM is supported by the Fundação para a Ciência e Tecnologia (FCT) grant SFRH/BD/143744/2019.

Supporting image 1

Figure 1. Methodology of low dose Computed Tomography Hounsfield Units (HU) measurement. 1a: Using a
three-dimensional curved multiplanar reconstruction, the curve of the spine adjacent to the spinal canal was delimited.
1b: On the obtained sagittal image, each vertebra (from C3 to L5) was identifiable. At each vertebra, two lines of
reference were positioned at the superior (yellow line A) and inferior (yellow line C) limits of the vertebra. Equidistant to
A and C, the yellow line B was positioned by the software at the center of the vertebral body. 1c: Vertebral
HU measurements were taken from the reconstructed cross-sectional slice positioned at the center of the vertebra. A
region of interest was manually selected, having a diameter equal to 75% of the average of anteroposterior and
transverse diameters. The density of the vertebra was displayed by the software as the average image intensity within
the sample region, reported in HU.

Supporting image 2

Table 1. Change scores for each reader, mean differences between readers, intraclass correlation coefficients (ICC), and agreement on changes beyond measurement error, from C3 to L5. § C3-C7: n=44; T1-L5: n=49. # Percentages of agreement on changes beyond measurement error, i.e., above the absolute value of the smallest detectable change (>|SDC|= >SDC and <-SDC). For consistency, the mean/median SDC of 7 was used as a cut-off to assess changes beyond measurement error in all vertebrae. *Percentage of agreement on change scores within measurement error (<|SDC|= ≤SDC and ≥-SDC).


Disclosures: M. Marques, None; N. Pereira da Silva, None; D. van der Heijde, AbbVie, Bayer, BMS, Cyxone, Eisai, Galapagos, Gilead, Glaxo-Smith-Kline, Janssen, Novartis, Pfizer, UCB, Imaging Rheumatology bv, Lilly; M. Reijnierse, ASAS, International Skeletal Society; J. Braun, None; X. Baraliakos, AbbVie, Lilly, Galapagos, MSD, Novartis, Pfizer, UCB, Bristol-Myers Squibb, Janssen, Roche, Sandoz, Sanofi; f. van Gaalen, Stichting vrienden van Sole Mio, Stichting ASAS, Jacobus stichting, Novartis, UCB, MSD, AbbVie, Bristol Myers Squibb, Eli Lilly; S. Ramiro, AbbVie/Abbott, Eli Lilly, Galapagos, Merck/MSD, Novartis, Pfizer, UCB, Sanofi.

To cite this abstract in AMA style:

Marques M, Pereira da Silva N, van der Heijde D, Reijnierse M, Braun J, Baraliakos X, van Gaalen f, Ramiro S. Low Dose Computed Tomography Hounsfield Units: A Reliable Methodology for Assessing Changes in Vertebral Bone Density in Radiographic Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/low-dose-computed-tomography-hounsfield-units-a-reliable-methodology-for-assessing-changes-in-vertebral-bone-density-in-radiographic-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/low-dose-computed-tomography-hounsfield-units-a-reliable-methodology-for-assessing-changes-in-vertebral-bone-density-in-radiographic-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology